Efficacy and Safety of Esketamine Combined With Dexmedetomidine in Non-Invasive ICU Patients With Hyperactive Delirium (ESSENTIAL Trial): Protocol of a Randomized Controlled Trial | MicrobiomeTrials
Efficacy and Safety of Esketamine Combined With Dexmedetomidine in Non-Invasive ICU Patients With Hyperactive Delirium (ESSENTIAL Trial): Protocol of a Randomized Controlled Trial
RecruitingPHASE4INTERVENTIONAL
Trial Details
Start: 2026-07-01Est. Completion: 2029-01-01
Enrollment target: 388 participants
Locations
The First Affiliated Hospital with Nanjing Medical University, Nanjing, Jiangsu, China